Laurent Salphati

7.3k total citations
67 papers, 2.9k citations indexed

About

Laurent Salphati is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Laurent Salphati has authored 67 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 24 papers in Molecular Biology and 20 papers in Pharmacology. Recurrent topics in Laurent Salphati's work include Drug Transport and Resistance Mechanisms (30 papers), Pharmacogenetics and Drug Metabolism (19 papers) and Pharmacological Effects and Toxicity Studies (16 papers). Laurent Salphati is often cited by papers focused on Drug Transport and Resistance Mechanisms (30 papers), Pharmacogenetics and Drug Metabolism (19 papers) and Pharmacological Effects and Toxicity Studies (16 papers). Laurent Salphati collaborates with scholars based in United States, China and France. Laurent Salphati's co-authors include Leslie Z. Benet, Vincent J. Wacher, Jashvant D. Unadkat, Cornelis E. C. A. Hop, Raymond Evers, Bhagwat Prasad, Leslie Z. Benet, Xiaoyan Chu, Anshul Gupta and Guangqing Xiao and has published in prestigious journals such as Cancer Research, Advanced Drug Delivery Reviews and Clinical Cancer Research.

In The Last Decade

Laurent Salphati

67 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laurent Salphati United States	30	1.7k	935	876	777	253	67	2.9k
Jan Snoeys Belgium	33	897 0.5×	906 1.0×	1.2k 1.4×	451 0.6×	141 0.6×	94	3.7k
Thomayant Prueksaritanont United States	37	1.7k 1.0×	1.6k 1.7×	1.6k 1.9×	810 1.0×	99 0.4×	124	5.2k
Oliver von Richter Germany	25	2.9k 1.7×	1.5k 1.6×	973 1.1×	1.8k 2.3×	181 0.7×	66	4.6k
Masato Chiba Japan	35	1.7k 1.0×	1.2k 1.2×	1.1k 1.3×	519 0.7×	689 2.7×	114	3.7k
Sook Wah Yee United States	41	2.0k 1.2×	854 0.9×	1.8k 2.1×	1.2k 1.5×	141 0.6×	101	5.1k
Chi‐Yuan Wu United States	15	1.5k 0.8×	971 1.0×	429 0.5×	805 1.0×	109 0.4×	19	3.0k
Balram Chowbay Singapore	37	1.7k 1.0×	1.3k 1.4×	1.4k 1.6×	611 0.8×	514 2.0×	109	4.2k
Gian Camenisch Switzerland	26	915 0.5×	525 0.6×	871 1.0×	295 0.4×	106 0.4×	56	2.5k
Sibylle Neuhoff United Kingdom	30	1.6k 0.9×	968 1.0×	503 0.6×	794 1.0×	63 0.2×	68	2.8k
Laurent P. Rivory Australia	35	2.2k 1.3×	739 0.8×	2.0k 2.2×	319 0.4×	407 1.6×	96	4.0k

Countries citing papers authored by Laurent Salphati

Since Specialization

Citations

This map shows the geographic impact of Laurent Salphati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Salphati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Salphati more than expected).

Fields of papers citing papers by Laurent Salphati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Salphati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Salphati. The network helps show where Laurent Salphati may publish in the future.

Co-authorship network of co-authors of Laurent Salphati

This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Salphati. A scholar is included among the top collaborators of Laurent Salphati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Salphati. Laurent Salphati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cho, Sungjoon, Lionel Cheruzel, Jingwei Cai, et al.. (2024). Discovery of Unprecedented Human Stercobilin Conjugates. Drug Metabolism and Disposition. 52(9). 981–987. 3 indexed citations

An, Le, Tom De Bruyn, Jodie Pang, et al.. (2024). Early Stage Preclinical Formulation Strategies to Alter the Pharmacokinetic Profile of Two Small Molecule Therapeutics. Pharmaceuticals. 17(2). 179–179. 1 indexed citations

Kumar, Vineet, Kazuya Ishida, Laurent Salphati, et al.. (2020). Prediction of Transporter-Mediated Rosuvastatin Hepatic Uptake Clearance and Drug Interaction in Humans Using Proteomics-Informed REF Approach. Drug Metabolism and Disposition. 49(2). 159–168. 27 indexed citations

Billington, Sarah, Steven C. Shoner, Scott D. Lee, et al.. (2019). Positron Emission Tomography Imaging of [¹¹C]Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of Cyclosporin A. Clinical Pharmacology & Therapeutics. 106(5). 1056–1066. 50 indexed citations

Billington, Sarah, Laurent Salphati, Cornelis E. C. A. Hop, et al.. (2019). Interindividual and Regional Variability in Drug Transporter Abundance at the Human Blood–Brain Barrier Measured by Quantitative Targeted Proteomics. Clinical Pharmacology & Therapeutics. 106(1). 228–237. 60 indexed citations

Juric, Dejan, Ian E. Krop, Ramesh K. Ramanathan, et al.. (2017). Phase I Dose-Escalation Study of Taselisib, an Oral PI3K Inhibitor, in Patients with Advanced Solid Tumors. Cancer Discovery. 7(7). 704–715. 120 indexed citations

Safina, Brian S., Richard L. Elliott, Andrew K. Forrest, et al.. (2017). Design of Selective Benzoxazepin PI3Kδ Inhibitors Through Control of Dihedral Angles. ACS Medicinal Chemistry Letters. 8(9). 936–940. 22 indexed citations

Chiang, Po‐Chang, Jodie Pang, Jia Liu, & Laurent Salphati. (2017). An Investigation of Oral Exposure Variability and Formulation Strategy: A Case Study of PI3Kδ Inhibitor and Physiologically Based Pharmacokinetic Modeling in Beagle Dogs. Journal of Pharmaceutical Sciences. 107(1). 466–475. 4 indexed citations

Osswald, Matthias, Jonas Blaes, Yunxiang Liao, et al.. (2016). Impact of Blood–Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain Metastases. Clinical Cancer Research. 22(24). 6078–6087. 88 indexed citations

10.

Yang, Wei, Lloye M. Dillon, Kevin Shee, et al.. (2016). Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha–Positive, PIK3CA -Mutant Breast Cancer. Clinical Cancer Research. 22(9). 2250–2260. 27 indexed citations

11.

Koehler, Michael F. T., Philippe Bergeron, Elizabeth M. Blackwood, et al.. (2016). Development of a Potent, Specific CDK8 Kinase Inhibitor Which Phenocopies CDK8/19 Knockout Cells. ACS Medicinal Chemistry Letters. 7(3). 223–228. 65 indexed citations

12.

Kumar, Vineet, Bhagwat Prasad, Gabriela I. Patilea‐Vrana, et al.. (2014). Quantitative Transporter Proteomics by Liquid Chromatography with Tandem Mass Spectrometry: Addressing Methodologic Issues of Plasma Membrane Isolation and Expression-Activity Relationship. Drug Metabolism and Disposition. 43(2). 284–288. 41 indexed citations

13.

Wang, Li, Bhagwat Prasad, Laurent Salphati, et al.. (2014). Interspecies Variability in Expression of Hepatobiliary Transporters across Human, Dog, Monkey, and Rat as Determined by Quantitative Proteomics. Drug Metabolism and Disposition. 43(3). 367–374. 143 indexed citations

14.

Salphati, Laurent, Xiaoyan Chu, Liangfu Chen, et al.. (2014). Evaluation of Organic Anion Transporting Polypeptide 1B1 and 1B3 Humanized Mice as a Translational Model to Study the Pharmacokinetics of Statins. Drug Metabolism and Disposition. 42(8). 1301–1313. 30 indexed citations

15.

Salphati, Laurent, Sheerin Shahidi-Latham, Kai Barck, et al.. (2014). Distribution of the Phosphatidylinositol 3-Kinase Inhibitors Pictilisib (GDC-0941) and GNE-317 in U87 and GS2 Intracranial Glioblastoma Models—Assessment by Matrix-Assisted Laser Desorption Ionization Imaging. Drug Metabolism and Disposition. 42(7). 1110–1116. 36 indexed citations

16.

Pai, Rama, Dorothy French, Ning Ma, et al.. (2012). Antibody-Mediated Inhibition of Fibroblast Growth Factor 19 Results in Increased Bile Acids Synthesis and Ileal Malabsorption of Bile Acids in Cynomolgus Monkeys. Toxicological Sciences. 126(2). 446–456. 62 indexed citations

17.

Plise, Emile G., Daniel Tran, & Laurent Salphati. (2010). Semi-Automated Protein Binding Methodology Using Equilibrium Dialysis and A Novel Mixed-Matrix Cassette Approach. Journal of Pharmaceutical Sciences. 99(12). 5070–5078. 6 indexed citations

18.

Salphati, Laurent, Leslie B. Lee, Jodie Pang, Emile G. Plise, & Xiaolin Zhang. (2010). Role of P-Glycoprotein and Breast Cancer Resistance Protein-1 in the Brain Penetration and Brain Pharmacodynamic Activity of the Novel Phosphatidylinositol 3-Kinase Inhibitor GDC-0941. Drug Metabolism and Disposition. 38(9). 1422–1426. 20 indexed citations

19.

Salphati, Laurent & Leslie Z. Benet. (1998). Modulation of P-glycoprotein expression by cytochrome P450 3A inducers in male and female rat livers. Biochemical Pharmacology. 55(4). 387–395. 128 indexed citations

20.

Salphati, Laurent & Leslie Z. Benet. (1998). Effects of Ketoconazole on Digoxin Absorption and Disposition in Rat. Pharmacology. 56(6). 308–313. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact